In T2DM, GIP has a limited ability to stimulate insulin secretion during hyperglycemia and does not significantly reduce blood glucose concentrations, whereas GLP-1 still significantly regulates blood glucose concentrations in patients with T2DM [126]. Here, INS is linked to Hyperglycemia.